RAPGEF4 and cardiac rhythm disease: Current findings using rat hearts have implied that the cardioprotective effect induced by urocortin‐1 is mediated by activation of Epac2 (Calderon‐Sanchez et al.,2016) and that Epac2 inhibition promotes cardiac arrhythmias (Yang et al.,2016).